Cardif (MAVS) regulates the maturation of NK cells

Journal of Immunology

Volumn 195, Issue 5, 2015, Pages 2157-2167

  Haynes, Lateira D ^a   Verma, Shilpi ^a   McDonald, Bryan ^a   Wu, Runpei ^a   Tacke, Robert ^a   Nowyhed, Heba N ^a   Ekstein, Jennifer ^a   Feuvrier, Ariana ^a   Benedict, Chris A ^a   Hedrick, Catherine C ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD11B ANTIGEN; GAMMA INTERFERON; PROTEIN CARDIF; STAT1 PROTEIN; UNCLASSIFIED DRUG; IPS-1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STAT1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; FEMALE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; WILD TYPE; 3T3 CELL LINE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOTOXICITY; FLOW CYTOMETRY; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; LYMPHOCYTE COUNT; MALE; METABOLISM; MUROMEGALOVIRUS; PHYSIOLOGY; SPLEEN; VIROLOGY; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HERPESVIRIDAE INFECTIONS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; NIH 3T3 CELLS; SPLEEN; STAT1 TRANSCRIPTION FACTOR;

EID: 84940112281     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402060     Document Type: Article

References (78)

1. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
2. Ireton, R. C., and M. Gale, Jr. 2011. RIG-I like receptors in antiviral immunity and therapeutic applications. Viruses 3: 906-919.
3. Eisenächer, K., and A. Krug. 2012. Regulation of RLR-mediated innate immune signaling-it is all about keeping the balance. Eur. J. Cell Biol. 91: 36-47.
4. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIGI antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
5. Seth, R. B., L. Sun, C.-K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
6. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5- mediated type I interferon induction. Nat. Immunol. 6: 981-988.
7. Xu, L.-G., Y.-Y. Wang, K.-J. Han, L.-Y. Li, Z. Zhai, and H.-B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727-740.
8. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13: 816-825.
9. Takamatsu, S., K. Onoguchi, K. Onomoto, R. Narita, K. Takahasi, F. Ishidate, T. K. Fujiwara, M. Yoneyama, H. Kato, and T. Fujita. 2013. Functional characterization of domains of IPS-1 using an inducible oligomerization system. PLoS One 8: e53578.
10. Loo, Y.-M., and M. Gale, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
11. Li, X. D., Y. H. Chiu, A. S. Ismail, C. L. Behrendt, M. Wight-Carter, L. V. Hooper, and Z. J. Chen. 2011. Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis. Proc. Natl. Acad. Sci. USA 108: 17390-17395.
12. Wang, Y., H.-X. Zhang, Y.-P. Sun, Z.-X. Liu, X.-S. Liu, L. Wang, S.-Y. Lu, H. Kong, Q.-L. Liu, X.-H. Li, et al. 2007. Rig-I-/- mice develop colitis associated with downregulation of G alpha i2. Cell Res. 17: 858-868.
13. Xu, L.-G., L. Jin, B.-C. Zhang, L. J. Akerlund, H.-B. Shu, and J. C. Cambier. 2012. VISA is required for B cell expression of TLR7. J. Immunol. 188: 248-258.
14. Subramanian, N., K. Natarajan, M. R. Clatworthy, Z. Wang, and R. N. Germain. 2013. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153: 348-361.
15. Wang, F., W. Xia, F. Liu, J. Li, G. Wang, and J. Gu. 2012. Interferon regulator factor 1/retinoic inducible gene I (IRF1/RIG-I) axis mediates 25- hydroxycholesterol-induced interleukin-8 production in atherosclerosis. Cardiovasc. Res. 93: 190-199.
16. Dann, A., H. Poeck, A. L. Croxford, S. Gaupp, K. Kierdorf, M. Knust, D. Pfeifer, C. Maihoefer, S. Endres, U. Kalinke, et al. 2012. Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat. Neurosci. 15: 98-106.
17. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510.
18. Gordon, S. M., J. Chaix, L. J. Rupp, J.Wu, S. Madera, J. C. Sun, T. Lindsten, and S. L. Reiner. 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36: 55-67.
19. Daussy, C., F. Faure, K. Mayol, S. Viel, G. Gasteiger, E. Charrier, J. Bienvenu, T. Henry, E. Debien, U. A. Hasan, et al. 2014. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 211: 563-577.
20. Fathman, J. W., D. Bhattacharya, M. A. Inlay, J. Seita, H. Karsunky, and I. L. Weissman. 2011. Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 118: 5439-5447.
21. De Colvenaer, V., S. Taveirne, M. Delforche, M. De Smedt, B. Vandekerckhove, T. Taghon, L. Boon, J. Plum, and G. Leclercq. 2011. CD27-deficient mice show normal NK-cell differentiation but impaired function upon stimulation. Immunol. Cell Biol. 89: 803-811.
22. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176: 1517-1524.
23. Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T.Walzer. 2009.Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
24. Fu, B., F. Wang, R. Sun, B. Ling, Z. Tian, and H. Wei. 2011. CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 133: 350-359.
25. Huntington, N. D., H. Tabarias, K. Fairfax, J. Brady, Y. Hayakawa, M. A. Degli-Esposti, M. J. Smyth, D. M. Tarlinton, and S. L. Nutt. 2007. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 178: 4764-4770.
26. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.
27. Swann, J. B., Y. Hayakawa, N. Zerafa, K. C. F. Sheehan, B. Scott, R. D. Schreiber, P. Hertzog, and M. J. Smyth. 2007. Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J. Immunol. 178: 7540-7549.
28. Mizutani, T., N. Neugebauer, E. M. Putz, N.Moritz, O. Simma, E. Zebedin-Brandl, D. Gotthardt, W. Warsch, E. Eckelhart, H. P. Kantner, et al. 2012. Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance. OncoImmunology 1: 1027-1037.
29. Lee, C. K., D. T. Rao, R. Gertner, R. Gimeno, A. B. Frey, and D. E. Levy. 2000. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165: 3571-3577.
30. Gough, D. J., N. L. Messina, C. J. P. Clarke, R. W. Johnstone, and D. E. Levy. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174.
31. Miyagi, T., M. P. Gil, X. Wang, J. Louten, W.-M. Chu, and C. A. Biron. 2007. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 204: 2383-2396.
32. Mack, E. A., L. E. Kallal, D. A. Demers, and C. A. Biron. 2011. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection. MBio 2: e00169-e11.
33. Michallet, M.-C., E. Meylan, M. A. Ermolaeva, J. Vazquez, M. Rebsamen, J. Curran, H. Poeck, M. Bscheider, G. Hartmann, M. König, et al. 2008. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28: 651-661.
34. Hanna, R. N., L. M. Carlin, H. G. Hubbeling, D. Nackiewicz, A. M. Green, J. A. Punt, F. Geissmann, and C. C. Hedrick. 2011. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6Cmonocytes. Nat. Immunol. 12: 778-785.
35. McWhorter, A. R., L. M. Smith, L. L. Masters, B. Chan, G. R. Shellam, and A. J. Redwood. 2013. Natural killer cell dependent within-host competition arises during multiple MCMVinfection: consequences for viral transmission and evolution. PLoS Pathog. 9: e1003111.
36. Verma, S., Q. Wang, G. Chodaczek, and C. A. Benedict. 2013. Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus. J. Virol. 87: 6201-6210.
37. Seillet, C., N. D. Huntington, P. Gangatirkar, E. Axelsson, M. Minnich, H. J. M. Brady, M. Busslinger, M. J. Smyth, G. T. Belz, and S. Carotta. 2014. Differential requirement for Nfil3 during NK cell development. J. Immunol. 192: 2667-2676.
38. Sun, J. C. 2010. Re-educating natural killer cells. J. Exp. Med. 207: 2049-2052.
39. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y.-J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
40. Yokoyama, W. M., and S. Kim. 2006. Licensing of natural killer cells by selfmajor histocompatibility complex class I. Immunol. Rev. 214: 143-154.
41. Robbins, S. H., M. S. Tessmer, L. Van Kaer, and L. Brossay. 2005. Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation. Eur. J. Immunol. 35: 757-765.
42. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
43. Beuneu, H., J. Deguine, I. Bouvier, J. P. Di Santo, M. L. Albert, and P. Bousso. 2011. Cutting edge: a dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation. J. Immunol. 187: 2084-2088.
44. Marçais, A., S. Viel, M. Grau, T. Henry, J. Marvel, and T. Walzer. 2013. Regulation of mouse NK cell development and function by cytokines. Front. Immunol. 4: 450.
45. Brady, J., S. Carotta, R. P. L. Thong, C. J. Chan, Y. Hayakawa, M. J. Smyth, and S. L. Nutt. 2010. The interactions of multiple cytokines control NK cell maturation. J. Immunol. 185: 6679-6688.
46. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
47. Bubić, I., M. Wagner, A. Krmpotić, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjić, and U. H. Koszinowski. 2004. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78: 7536-7544.
48. Orr, M. T., J. C. Sun, D. G. T. Hesslein, H. Arase, J. H. Phillips, T. Takai, and L. L. Lanier. 2009. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J. Exp. Med. 206: 807-817.
49. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, andW.M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
50. Schneider, K., A. Loewendorf, C. De Trez, J. Fulton, A. Rhode, H. Shumway, S. Ha, G. Patterson, K. Pfeffer, S. A. Nedospasov, et al. 2008. Lymphotoxinmediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3: 67-76.
51. Maslowski, K. M., A. T. Vieira, A. Ng, J. Kranich, F. Sierro, D. Yu, H. C. Schilter, M. S. Rolph, F. Mackay, D. Artis, et al. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461: 1282-1286.
52. El Maadidi, S., L. Faletti, B. Berg, C. Wenzl, K. Wieland, Z. J. Chen, U. Maurer, and C. Borner. 2014. A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosis. J. Immunol. 192: 1171-1183.
53. Samson, S. I., S. Mémet, C. A. Vosshenrich, F. Colucci, O. Richard, D. Ndiaye, A. Israël, and J. P. Di Santo. 2004. Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation. Blood 103: 4573-4580.
54. Pascal, V., N. R. Nathan, E. Claudio, U. Siebenlist, and S. K. Anderson. 2007. NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK cells. J. Immunol. 179: 1751-1759.
55. Tato, C. M., N. Mason, D. Artis, S. Shapira, J. C. Caamano, J. H. Bream, H.-C. Liou, and C. A. Hunter. 2006. Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-γamma. Int. Immunol. 18: 505-513.
56. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
57. Baranek, T., T.-P. V. Manh, Y. Alexandre, M. A. Maqbool, J. Z. Cabeza, E. Tomasello, K. Crozat, G. Bessou, N. Zucchini, S. H. Robbins, et al. 2012. Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. [Published erratum appears in 2013 Cell Host Microbe 13: 372.] Cell Host Microbe 12: 571-584.
58. Lee, G. A., Y.-H. Liou, S.-W. Wang, K.-L. Ko, S.-T. Jiang, and N.-S. Liao. 2011. Different NK cell developmental events require different levels of IL-15 transpresentation. J. Immunol. 187: 1212-1221.
59. Castillo, E. F., and K. S. Schluns. 2012. Regulating the immune system via IL-15 transpresentation. Cytokine 59: 479-490.
60. Gordy, L. E., J. S. Bezbradica, A. I. Flyak, C. T. Spencer, A. Dunkle, J. Sun, A. K. Stanic, M. R. Boothby, Y.-W. He, Z. Zhao, et al. 2011. IL-15 regulates homeostasis and terminal maturation of NKT cells. J. Immunol. 187: 6335-6345.
61. Verma, S., and C. A. Benedict. 2011. Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus. J. Interferon Cytokine Res. 31: 211-218.
62. Döring, M., I. Lessin, T. Frenz, J. Spanier, A. Kessler, P. Tegtmeyer, F. Dag, N. Thiel, M. Trilling, S. Lienenklaus, et al. 2014. M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells. J. Virol. 88: 13638-13650.
63. Orr, M. T., W. J. Murphy, and L. L. Lanier. 2010. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11: 321-327.
64. Orr, M. T., and L. L. Lanier. 2011. Natural killer cell licensing during viral infection. In Crossroads between Innate and Adaptive Immunity III. Advances in Experimental Medicine and Biology, Vol. 780. B. Pulendran, P. D. Katsikis, and S. P. Schoenberger, eds. New York: Springer, p. 37-44.
65. Pothlichet, J., T. B. Niewold, D. Vitour, B. Solhonne, M. K. Crow, and M. Si- Tahar. 2011. A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Mol. Med. 3: 142-152.
66. Molineros, J. E., A. K. Maiti, C. Sun, L. L. Looger, S. Han, X. Kim-Howard, S. Glenn, A. Adler, J. A. Kelly, T. B. Niewold, et al; BIOLUPUS Network. 2013. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet. 9: e1003222.
67. Poggi, A., and M. R. Zocchi. 2014. NK cell autoreactivity and autoimmune diseases. Front. Immunol. 5: 27.
68. Park, Y.-W., S.-J. Kee, Y.-N. Cho, E.-H. Lee, H.-Y. Lee, E.-M. Kim, M.-H. Shin, J.-J. Park, T.-J. Kim, S.-S. Lee, et al. 2009. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 60: 1753-1763.
69. Henriques, A., L. Teixeira, L. Inês, T. Carvalheiro, A. Gonçalves, A. Martinho, M. L. Pais, J. A. P. da Silva, and A. Paiva. 2013. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity. Clin. Rheumatol. 32: 805-813.
70. Hervier, B., V. Beziat, J. Haroche, A. Mathian, P. Lebon, P. Ghillani-Dalbin, L. Musset, P. Debré, Z. Amoura, and V. Vieillard. 2011. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-g production in patients with active disease. Arthritis Rheum. 63: 1698-1706.
71. Schepis, D., I. Gunnarsson, M.-L. Eloranta, J. Lampa, S. H. Jacobson, K. Kärre, and L. Berg. 2009. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 126: 140-146.
72. Malathi, K., B. Dong, M. Gale, Jr., and R. H. Silverman. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819.
73. Ezelle, H. J., and B. A. Hassel. 2012. Pathologic effects of RNase-L dysregulation in immunity and proliferative control. Front. Biosci. (Schol Ed). 4: 767-786.
74. Cho, J. A., A. H. Lee, B. Platzer, B. C. Cross, B. M. Gardner, H. De Luca, P. Luong, H. P. Harding, L. H. Glimcher, P. Walter, et al. 2013. The unfolded protein response element IRE1a senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. Cell Host Microbe 13: 558-569.
75. Malathi, K., T. Saito, N. Crochet, D. J. Barton, M. Gale, Jr., and R. H. Silverman. 2010. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16: 2108-2119.
76. Zeng, M., Z. Hu, X. Shi, X. Li, X. Zhan, X. D. Li, J. Wang, J. H. Choi, K. W. Wang, T. Purrington, et al. 2014. MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses. Science 346: 1486-1492.
77. Grasset, E. K., and A. Cerutti. 2014. Immunology. Retroviral help for B cells. Science 346: 1454-1455.
78. Dupuis-Maurin, V., L. Brinza, J. Baguet, E. Plantamura, S. Schicklin, S. Chambion, C. Macari, M. Tomkowiak, E. Deniaud, Y. Leverrier, et al. 2015. Overexpression of the transcription factor Sp1 activates the OAS-RNAse L-RIGI pathway. PLoS One 10: e0118551.